You are viewing: India AI in Precision Medicine Market analysis

The India AI in Precision Medicine Market was valued at $1.54 Million in 2024 and projected to reach to $5.49 Million by 2029, representing a compound annual growth rate of 18.5%. India's AI in Precision Medicine market is poised for substantial growth as healthcare providers increasingly adopt AI technologies to address the nation's disease burden and improve diagnostic accuracy.

India AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India AI in Precision Medicine Market Trends and Insights

  • India is emerging as a key hub for AI-driven diagnostic and therapeutic innovations, driven by increasing healthcare digitalization, rising prevalence of chronic diseases, and growing investment in healthcare infrastructure.
  • The market in India is benefiting from a large patient population, expanding telemedicine adoption, and government initiatives supporting digital health transformation. India's precision medicine ecosystem is accelerating as healthcare providers and pharmaceutical companies integrate AI technologies for drug discovery, genomic analysis, and personalized treatment planning.
  • India's competitive advantage in software development and data analytics is positioning the country as a significant player in global precision medicine innovation.
  • Between 2024 and 2029, India is expected to witness heightened adoption of AI-powered diagnostic tools, predictive analytics platforms, and clinical decision support systems across hospitals, diagnostic centers, and research institutions..

Key Market Statistics

  • CAGR (2024-2029) 18.5% CAGR
  • Market Size, 2024 ~USD 1.54 Million
  • Forecast, 2029 ~USD 5.49 Million
  • Country India

India AI in Precision Medicine Market Overview

Rapid Market Expansion :

India's AI in Precision Medicine market is projected to grow from USD 1.54 billion in 2024 to USD 5.49 billion by 2029, with a CAGR of 18.5%, significantly outpacing many developed markets in adoption velocity.

Healthcare Digitalization Drive :

Government initiatives like Digital India and National Health Stack are accelerating AI adoption in diagnostic imaging, genomic analysis, and personalized treatment protocols across Indian healthcare institutions.

Chronic Disease Burden :

Rising prevalence of diabetes, cardiovascular diseases, and cancer in India is driving demand for AI-powered precision diagnostics and targeted therapies to improve patient outcomes and reduce healthcare costs.

Emerging Innovation Hub :

India is establishing itself as a global center for AI-driven medical research and development, with increasing investments from both domestic startups and international pharmaceutical companies establishing R&D centers.

India AI in Precision Medicine Market Dynamics

  • The convergence of government digital health initiatives, rising healthcare expenditure, and a large patient population creates a compelling market opportunity.
  • Investments in AI infrastructure, coupled with growing collaborations between Indian tech companies and healthcare providers, are accelerating innovation in personalized treatment pathways and predictive analytics. The market will be further propelled by India's cost-effective AI solutions attracting global pharmaceutical companies and the emergence of homegrown AI startups focused on precision medicine.
  • However, regulatory standardization, data privacy frameworks, and healthcare professional training remain critical factors for sustained market expansion through 2029..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • India's AI in Precision Medicine market is valued at USD 1.54 billion in 2024 and is forecast to reach USD 5.49 billion by 2029, growing at a 18.5% CAGR.
        • India's large patient population and rising chronic disease burden are driving demand for AI-powered diagnostic and personalized treatment solutions.
        • India's strength in software development and data analytics is positioning the country as a competitive hub for precision medicine innovation and global outsourcing.
        • Government digital health initiatives and expanding healthcare infrastructure in India are accelerating AI adoption across diagnostic centers, hospitals, and research institutions.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        India AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        INDIA: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030

        Segment202220232024202520262027202820292030CAGR (%)
        HEALTHCARE PROVIDERS5.096.458.1610.3313.0716.5320.926.4133.3726.4
        MEDICAL DEVICE/EQUIPMENT COMPANIES3.264.115.186.538.2210.3513.0316.420.6325.9
        OTHER END USERS1.21.51.872.342.923.644.545.657.0424.7
        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES4.155.146.377.899.7612.0814.9418.4722.8223.7
        RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS2.533.113.824.695.767.068.6710.6313.0322.7
        TOTAL16.2220.325.431.7739.7349.6762.0777.5696.8925

        Target Audience

        • Healthcare Technology Investors : Venture capitalists and private equity firms seeking high-growth opportunities in India's digital health sector need market sizing, growth trajectory, and investment landscape data to identify promising AI precision medicine startups and funding opportunities.
        • Pharmaceutical & Biotech Companies : Global and Indian pharmaceutical firms require India-specific market intelligence to develop precision medicine strategies, identify partnership opportunities, and understand competitive dynamics for drug development and personalized treatment solutions.
        • Healthcare Providers & Hospital Networks : Hospital chains and diagnostic centers need market insights to evaluate AI precision medicine adoption ROI, benchmark against peers, and make informed technology investment decisions aligned with India's healthcare transformation agenda.
        • AI & Software Solution Providers : Technology companies developing AI diagnostic and therapeutic platforms require India market data to assess addressable market size, customer segments, regulatory requirements, and competitive positioning for product localization and go-to-market strategies.
        • Government & Policy Makers : Healthcare ministry officials and policy advisors need comprehensive market analysis to inform digital health initiatives, precision medicine roadmaps, and regulatory frameworks supporting India's emergence as a global precision medicine hub.

        Reasons to Buy this Report

        • Market Size & Growth Validation : Obtain precise market valuation data for India (USD 1.54B in 2024) with verified 5-year forecasts to support investment decisions, business planning, and competitive positioning in this high-growth segment.
        • India-Specific Growth Drivers : Understand localized factors driving 18.5% CAGR including government digitalization programs, chronic disease prevalence, and healthcare infrastructure investments unique to the Indian market landscape.
        • Competitive Intelligence : Identify emerging Indian AI startups, multinational players establishing operations, and partnership opportunities within India's precision medicine ecosystem to inform market entry or expansion strategies.
        • Regulatory & Implementation Insights : Access India-specific regulatory frameworks, data governance requirements, and healthcare system integration challenges to navigate market entry and ensure compliant product deployment.
        • Strategic Investment Guidance : Leverage detailed India market analysis to identify high-potential segments, geographic hotspots, and customer segments for targeted investment allocation and resource optimization.

        Frequently asked questions

        What is the current market size of AI in Precision Medicine in India?

        India's AI in Precision Medicine market was valued at USD 1.54 billion in 2024 and is projected to grow to USD 5.49 billion by 2029.

        What is the expected growth rate for AI in Precision Medicine in India?

        India's AI in Precision Medicine market is expected to grow at a compound annual growth rate (CAGR) of 18.5% from 2024 to 2029.

        What are the main drivers of AI adoption in precision medicine across India?

        Key drivers in India include rising chronic disease prevalence, healthcare digitalization, government digital health initiatives, telemedicine expansion, and India's competitive advantage in software and data analytics.

        Which healthcare segments in India are adopting AI in precision medicine?

        India's adoption spans diagnostic centers, hospitals, research institutions, and pharmaceutical companies utilizing AI for drug discovery, genomic analysis, diagnostic tools, and clinical decision support systems.

        How does India's market compare to global AI in Precision Medicine trends?

        While the global market grows at 30.7% CAGR, India's 18.5% CAGR reflects a maturing but rapidly expanding market with significant growth potential driven by localized healthcare needs and cost-effective innovation.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status